Grant: Alliance Grants
Simon Fraser University
$25,000.00
Novel effects of nitric oxide on cholesterol metabolism
FY 2023-24
Summary
Nitric oxide (NO) is a bioactive gas that is important for many aspects of human biology and physiology. Its production by inducible NO synthase (iNOS) has defined roles in immune protection against infectious microbes, where it acts in locations that are outside cells. Although NO is a potent regulator of cell signaling, the effects of iNOS-derived NO within cells that produce it are poorly understood. To address this knowledge gap, Dr. Choy has used bulk RNA sequencing to examine gene expression programs that are different in cells that express iNOS or when iNOS is inhibited. Unexpectedly, genes that control cholesterol metabolism were the most differentially expressed genes that were affected by the inhibition of iNOS. Specifically, cholesterol metabolism genes were reduced in cells that were stimulated to express iNOS and were less reduced when iNOS was inhibited indicating that iNOS-derived NO may be contributing to the inhibition of cholesterol metabolism. The latter cell process is essential for energy metabolism, cell survival, and inflammation. Nothing is known about the relationship between NO and cholesterol metabolism in cell biology. The proposed collaboration will leverage expertise in iNOS and NO by Dr. Choy (Simon Fraser University) and in cholesterol metabolism by Dr. Suarez (Yale University) to experimentally validate and identify mechanisms by which iNOS-derived NO inhibits cellular cholesterol metabolism. An enhanced understanding of these traditionally disparate aspects of cell biology has the potential to provide new information on human biology that impacts immunology, infectious disease biology, and cardiovascular and lung disease.
Program
Alliance Grants
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
583378-2023
Name nom
Choy, Jonathan J
Department département
Molecular Biology and Biochemistry
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5111
Research subject group en
Cell biology
Research subject group fr
Signal transduction
Research subject en
Biologie cellulaire
Research subject fr
Transduction de signal
Application title
Novel effects of nitric oxide on cholesterol metabolism
Keyword
Cell biology; Cholesterol metabolism; Immunology; Nitric oxide
Application summary
Nitric oxide (NO) is a bioactive gas that is important for many aspects of human biology and physiology. Its production by inducible NO synthase (iNOS) has defined roles in immune protection against infectious microbes, where it acts in locations that are outside cells. Although NO is a potent regulator of cell signaling, the effects of iNOS-derived NO within cells that produce it are poorly understood. To address this knowledge gap, Dr. Choy has used bulk RNA sequencing to examine gene expression programs that are different in cells that express iNOS or when iNOS is inhibited. Unexpectedly, genes that control cholesterol metabolism were the most differentially expressed genes that were affected by the inhibition of iNOS. Specifically, cholesterol metabolism genes were reduced in cells that were stimulated to express iNOS and were less reduced when iNOS was inhibited indicating that iNOS-derived NO may be contributing to the inhibition of cholesterol metabolism. The latter cell process is essential for energy metabolism, cell survival, and inflammation. Nothing is known about the relationship between NO and cholesterol metabolism in cell biology. The proposed collaboration will leverage expertise in iNOS and NO by Dr. Choy (Simon Fraser University) and in cholesterol metabolism by Dr. Suarez (Yale University) to experimentally validate and identify mechanisms by which iNOS-derived NO inhibits cellular cholesterol metabolism. An enhanced understanding of these traditionally disparate aspects of cell biology has the potential to provide new information on human biology that impacts immunology, infectious disease biology, and cardiovascular and lung disease.